Skip to content

Antibiotics role in advanced cancer patients

Efficacy of antibiotics in patients with advanced cancer in a Respite Palliative Care Unit: A single center prospective observational study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057809
Enrollment
100
Registered
2023-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1]Patients with advanced cancer started on antibiotics (iv or oral) by treating physicians and admitted in respite care facility. 2] Not receiving any disease modifying treatment. 3] Age above 18 years 4] Able to communicate and understand English/Hindi. 5]Able to give written informed consent.

Exclusion criteria

Exclusion criteria: 1]Patients with impaired consciousness. 2]Actively dying patients.

Design outcomes

Primary

MeasureTime frame
PRIMARY: 1]To assess the change in symptom burden on the Edmonton symptom assessment scale-revised version (ESAS-r) with antibiotic use from day 0, day 5 to day 14. Timepoint: Day 0 Day 5 Day 14

Secondary

MeasureTime frame
To assess the change in worst patient reported symptom on the Edmonton symptom assessment scale-revised (ESAS-r) with antibiotic use from day 0, day 5 to day 14. ? To assess the change in clinical findings like fever, vital signs, systemic findings with antibiotic use use from day 0, day 3 to day 5 . ? To assess the change in quality of life using EORTC QLQ 15 use from day 0, day 5 to day 14. ? To understand the pattern of antibiotics used by physicians in patients on supportive care alone. ? To document organism growth & antibiotic sensitivity pattern in urine, pus, wound, sputum, or blood culture sent before starting antibiotics. ? To document any side effect due to procedure of antibiotics administration like anaphylaxis, rash, edema etc.Timepoint: Day 0 Day 5 Day 14

Countries

India

Contacts

Public ContactDr Shamali Poojary

Tata Memorial Hospital

shamalipoojary8@gamil.com02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026